1. Home
  2. IPSC vs GNE Comparison

IPSC vs GNE Comparison

Compare IPSC & GNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.03

Market Cap

405.8M

Sector

Health Care

ML Signal

HOLD

Logo Genie Energy Ltd. Class B Stock

GNE

Genie Energy Ltd. Class B Stock

HOLD

Current Price

$14.07

Market Cap

359.1M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPSC
GNE
Founded
2019
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Power Generation
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
405.8M
359.1M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
IPSC
GNE
Price
$2.03
$14.07
Analyst Decision
Strong Buy
Hold
Analyst Count
4
1
Target Price
$4.25
$16.00
AVG Volume (30 Days)
926.1K
68.9K
Earning Date
05-11-2026
05-04-2026
Dividend Yield
N/A
2.19%
EPS Growth
91.30
95.65
EPS
N/A
0.11
Revenue
$109,164,000.00
$425,202,000.00
Revenue This Year
N/A
$17.49
Revenue Next Year
N/A
$7.07
P/E Ratio
N/A
$128.45
Revenue Growth
1556.76
N/A
52 Week Low
$0.44
$12.69
52 Week High
$2.97
$20.71

Technical Indicators

Market Signals
Indicator
IPSC
GNE
Relative Strength Index (RSI) 41.12 48.78
Support Level $1.81 $13.44
Resistance Level $2.62 $14.76
Average True Range (ATR) 0.12 0.33
MACD -0.02 -0.03
Stochastic Oscillator 14.63 28.26

Price Performance

Historical Comparison
IPSC
GNE

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

About GNE Genie Energy Ltd. Class B Stock

Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.

Share on Social Networks: